BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31541986)

  • 1. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY; Tani J; Chang TS; Lin CS
    PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
    Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY; Park SB; Liu YT; Kwai N; Arnold R; Krishnan AV; Lin CS
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
    Wu J; Liu D; Yang L; Liu J
    Med Sci Monit; 2022 Jun; 28():e936323. PubMed ID: 35684937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory and motor axonal excitability testing in early diabetic neuropathy.
    Kristensen AG; Gylfadottir S; Itani M; Kuwabara S; Krøigård T; Khan KS; Finnerup NB; Andersen H; Jensen TS; Sindrup S; Tankisi H
    Clin Neurophysiol; 2021 Jul; 132(7):1407-1415. PubMed ID: 34030050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular filtration Rate, urine Albumin/ creatinine ratio and current perception threshold in patients with diabetic kidney disease.
    Pi CX; Gui TJ; He QD; Yin F; Cai RJ; Wang Y; Xue QX; Tian XK; Wang T; Zhe XW
    Diabetes Res Clin Pract; 2022 Jul; 189():109934. PubMed ID: 35640744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular autonomic neuropathy in chronic kidney diseases.
    Thapa L; Karki P; Sharma SK; Bajaj BK
    JNMA J Nepal Med Assoc; 2010; 49(178):121-8. PubMed ID: 21485597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
    Kavuru V; Senger RS; Robertson JL; Choudhury D
    PeerJ; 2023; 11():e14879. PubMed ID: 36874959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CS; Krishnan AV
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.
    Kwai NC; Nigole W; Poynten AM; Brown C; Krishnan AV
    PLoS One; 2016; 11(4):e0153389. PubMed ID: 27078166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
    Eid SA; Hinder LM; Zhang H; Eksi R; Nair V; Eddy S; Eichinger F; Park M; Saha J; Berthier CC; Jagadish HV; Guan Y; Pennathur S; Hur J; Kretzler M; Feldman EL; Brosius FC
    FASEB J; 2021 May; 35(5):e21467. PubMed ID: 33788970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
    Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
    Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
    [No Abstract]   [Full Text] [Related]  

  • 17. Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy.
    Liu H; Tan S; Ma Z; Gao Q; Yang W
    J Diabetes Investig; 2024 Jan; 15(1):106-112. PubMed ID: 37794740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
    Musolino M; Greco M; D'Agostino M; Tripodi L; Misiti R; Dragone F; Cianfrone P; Zicarelli M; Foti DP; Andreucci M; Bolignano D; Coppolino G
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541089
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
    Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.